Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

What should men know about prostate-specific antigen screening before giving informed consent?

Chan EC, Sulmasy DP.

Am J Med. 1998 Oct;105(4):266-74.

PMID:
9809686
[PubMed - indexed for MEDLINE]
2.

Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing.

Chan EC, Vernon SW, Haynes MC, O'Donnell FT, Ahn C.

J Gen Intern Med. 2003 May;18(5):350-6.

PMID:
12795733
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The impact of informed consent on patient interest in prostate-specific antigen screening.

Wolf AM, Nasser JF, Wolf AM, Schorling JB.

Arch Intern Med. 1996 Jun 24;156(12):1333-6.

PMID:
8651843
[PubMed - indexed for MEDLINE]
4.

Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?

O'Dell KJ, Volk RJ, Cass AR, Spann SJ.

J Fam Pract. 1999 Sep;48(9):682-8.

PMID:
10498074
[PubMed - indexed for MEDLINE]
5.

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

Am J Med. 1998 Jun;104(6):526-32.

PMID:
9674714
[PubMed - indexed for MEDLINE]
6.

Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.

Bunting PS, Goel V, Williams JI, Iscoe NA.

CMAJ. 1999 Jan 12;160(1):70-5.

PMID:
9934349
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cultural sensitivity and informed decision making about prostate cancer screening.

Chan EC, Haynes MC, O'Donnell FT, Bachino C, Vernon SW.

J Community Health. 2003 Dec;28(6):393-405.

PMID:
14620963
[PubMed - indexed for MEDLINE]
8.

The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.

Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM.

J Gen Intern Med. 1996 Jun;11(6):342-9.

PMID:
8803740
[PubMed - indexed for MEDLINE]
9.

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.

Lim LS, Sherin K; ACPM Prevention Practice Committee.

Am J Prev Med. 2008 Feb;34(2):164-70. doi: 10.1016/j.amepre.2007.10.003. Review. Erratum in: Am J Prev Med. 2008 May;34(5):454.

PMID:
18201648
[PubMed - indexed for MEDLINE]
10.

Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.

Mistry K, Cable G.

J Am Board Fam Pract. 2003 Mar-Apr;16(2):95-101.

PMID:
12665174
[PubMed - indexed for MEDLINE]
Free Article
11.

Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.

Woods VD, Montgomery SB, Herring RP, Gardner RW, Stokols D.

J Natl Med Assoc. 2006 Apr;98(4):492-504. Review.

PMID:
16623061
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
[PubMed - indexed for MEDLINE]
13.

Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.

Jønler M, Eddy B, Poulsen J.

Scand J Urol Nephrol. 2005;39(3):214-8.

PMID:
16118092
[PubMed - indexed for MEDLINE]
14.

Prostate-specific antigen testing to screen for prostate cancer.

Budenholzer BR.

J Fam Pract. 1995 Sep;41(3):270-8. Review.

PMID:
7544400
[PubMed - indexed for MEDLINE]
15.

Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.

van Vugt HA, Roobol MJ, Venderbos LD, Joosten-van Zwanenburg E, Essink-Bot ML, Steyerberg EW, Bangma CH, Korfage IJ.

Eur J Cancer. 2010 Feb;46(3):669-77. doi: 10.1016/j.ejca.2009.11.022.

PMID:
20022239
[PubMed - indexed for MEDLINE]
16.

Prostate specific antigen: a useful screening test?

Concato J.

Cancer J. 2000 Apr;6 Suppl 2:S188-92. Review.

PMID:
10803835
[PubMed - indexed for MEDLINE]
17.

Informed consent for PSA screening: does it happen?

Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J.

Eff Clin Pract. 1999 Jul-Aug;2(4):152-7.

PMID:
10539539
[PubMed - indexed for MEDLINE]
Free Article
18.

Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?

Chan EC, Vernon SW, O'Donnell FT, Ahn C, Greisinger A, Aga DW.

Am J Public Health. 2003 May;93(5):779-85.

PMID:
12721144
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.

Chan EC, Barry MJ, Vernon SW, Ahn C.

J Gen Intern Med. 2006 Mar;21(3):257-9.

PMID:
16637825
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Predictors of interest in prostate-specific antigen screening and the impact of informed consent: what should we tell our patients?

Wolf AM, Philbrick JT, Schorling JB.

Am J Med. 1997 Oct;103(4):308-14.

PMID:
9382123
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk